Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational, Open-label Study to Investigate Efficacy and Safety of Denecimig (Mim8) in Adults With Acquired Haemophilia A

NCT07830732 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07830732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07830732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational, Open-label Study to Investigate Efficacy and Safety of Denecimig (Mim8) in Adults With Acquired Haemophilia A
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 9, 2026
Completion date
March 23, 2029
Enrollment
84 (estimated)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilia a